Article
Association of the GGCX (CAA)16/17 repeat polymorphism with higher warfarin dose requirements in African Americans.
Pharmacogenetics and genomics - 1 Feb 2012
Cavallari Larisa H, Perera Minoli, Wadelius Mia, Deloukas Panos, Taube Gelson, Patel Shitalben R, Aquino-Michaels Keston, Viana Marlos A G, Shapiro Nancy L, Nutescu Edith A
Abstract excerpt
OBJECTIVE: Little is known about genetic contributors to higher than usual warfarin dose requirements, particularly for African Americans. This study tested the hypothesis that the γ-glutamyl carboxylase (GGCX) genotype contributes to warfarin dose requirements greater than 7.5 mg/day in an Afric...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
